OKUR
OnKure Therapeutics
OKUR
OKUR
41 hedge funds and large institutions have $50.8M invested in OnKure Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
66% less capital invested
Capital invested by funds: $149M → $50.8M (-$98.1M)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$65K | |
| 2 | +$62.7K | |
| 3 | +$31.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$25.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$23.4K |
Top Sellers
| 1 | -$242K | |
| 2 | -$214K | |
| 3 | -$147K | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$122K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$115K |